theMednetRegister
  • Community
    • Overview
    • Experts
    • Editors
    • Fellows
    • Code of conduct
    • AI Guidelines for Physicians
  • Company
    • About Us
    • FAQs
    • Privacy Policy
    • Terms of Use
    • Careers
    • Programs
  • News
    • News Releases
    • Press Coverage
    • Publications
    • Blog
  • Contact Us
  • Sign in

Nephrology

Hepatology   

Questions discussed in this category


Do you avoid peritoneal dialysis in cirrhotic patients with ascites?
3 Answers available

What is your approach to managing concurrent severe SIADH and large-volume malignant ascites when aggressive volume removal appears to exacerbate both symptoms and hyponatremia?
For example, would you consider alternatives to paracentesis (Denver shunt placement, CART therapy, or permanent tunneled catheters) that might better...
1 Answer available
2393023665


Papers discussed in this category


European journal of endocrinology, 2023 Aug 02
Effect of protein supplementation on plasma sodium levels in the syndrome of inappropriate antidiuresis: a monocentric, open-label, proof-of-concept study-the TREASURE study.

Medicine, 2016 Jan
Peritoneal Dialysis is Associated With A Better Survival in Cirrhotic Patients With Chronic Kidney Disease.

Clinical nephrology, 2011 Oct
Outcome of peritoneal dialysis in cirrhotic patients with end-stage renal disease: a 24-years' experience in Taiwan.

The American journal of medicine, 1992 Jul
Peritoneal dialysis in end-stage renal disease patients with preexisting chronic liver disease and ascites.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2002 Jul
Outcome of peritoneal dialysis in cirrhotic patients with chronic renal failure.

Related Topics in Nephrology

  • Hematologic Malignancies
  • Radiation Oncology
  • Gynecologic Oncology
  • Genitourinary Cancers
  • Melanoma/Skin Cancer
  • Pediatric Hematology/Oncology
  • Prostate Cancer
  • Medical Oncology
  • Endocrine Tumors
  • Lymphoma

Copyright © 2025 theMednet
All Rights Reserved.